Catalyst Pharmaceutical Partners Aktie
20,71
EUR
+0,15
EUR
+0,73
%
21,45
USD
-0,48
USD
-2,19
%
Catalyst Pharmaceutical Partners Aktie Analyse
| 21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
| 30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
| 14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
| 29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |